First Eagle Investment Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-103,081
| Closed | -$3.48M | – | 421 |
|
|
2023
Q4 | $3.48M | Sell |
103,081
-104,551
| -50% | -$3.53M | 0.01% | 286 |
|
|
2023
Q3 | $6.37M | Sell |
207,632
-36,640
| -15% | -$1.12M | 0.02% | 182 |
|
|
2023
Q2 | $9.79M | Buy |
244,272
+67,847
| +38% | +$2.72M | 0.03% | 98 |
|
|
2023
Q1 | $7.2M | Buy |
176,425
+93,412
| +113% | +$3.81M | 0.02% | 103 |
|
|
2022
Q4 | $3.21M | Buy |
83,013
+4,482
| +6% | +$173K | 0.01% | 193 |
|
|
2022
Q3 | $4.18M | Buy |
78,531
+8,706
| +12% | +$463K | 0.01% | 95 |
|
|
2022
Q2 | $4.07M | Buy |
69,825
+22,104
| +46% | +$1.29M | 0.01% | 89 |
|
|
2022
Q1 | $3.64M | Buy |
47,721
+22,889
| +92% | +$1.75M | 0.01% | 87 |
|
|
2021
Q4 | $1.49M | Buy |
+24,832
| New | +$1.49M | ﹤0.01% | 97 |
|